Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Disease Using the PET Ligand [18F]-PI-2620

NCT05456503 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05456503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05456503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Disease Using the PET Ligand [18F]-PI-2620
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Recruiting
Start date
September 19, 2022
Completion date
August 31, 2028
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitively normal, frontotemporal lobar degeneration